Replies to post #89329 on Biotech Values

[DewDiligence]

(MNTA) Watson, who is Amphastar’s partner for generic Lovenox, issued its pipeline update and 2010 guidance today:

http://finance.yahoo.com/news/Watson-Provides-Overview-of-prnews-1771183588.html?x=0&.v=1

Lovenox is nowhere to be found in WPI’s PR. As a MNTA investor, I like that!